Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$6.06 - $9.43 $375 - $584
-62 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$6.91 - $12.59 $30,238 - $55,093
-4,376 Reduced 98.6%
62 $0
Q3 2020

Nov 05, 2020

SELL
$10.61 - $13.96 $37,792 - $49,725
-3,562 Reduced 44.53%
4,438 $50,000
Q2 2020

Aug 07, 2020

BUY
$10.91 - $18.56 $87,280 - $148,480
8,000 New
8,000 $91,000

Others Institutions Holding LYRA

About Lyra Therapeutics, Inc.


  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $8.91M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.